Time to Initiation of the Second-Line Therapy Obeticholic Acid in Patients With Primary Biliary Cholangitis

被引：0
|
作者：
Kumar, Sonal [1 ]
Macewan, Joanna P. [2 ]
Levine, Alina [2 ]
Bessonova, Leona [3 ]
Nair, Radhika [3 ]
Wheeler, Darren [3 ]
Li, Jing [3 ]
Brown, Robert S. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Genesis Res Grp, Hoboken, NJ USA
[3] Intercept Pharmaceut Inc, Morristown, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001028872.30928.6d
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S126
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] Time to initiation of the second-line therapy obeticholic acid in patients with primary biliary cholangitis
    Kumar, Sonal
    MacEwan, Joanna P.
    Levine, Alina
    Bessonova, Leona
    Nair, Radhika
    Wheeler, Darren
    Li, Jing
    Brown, Robert S., Jr.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S314 - S315
  • [2] Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
    Reig, Anna
    Alvarez-Navascues, Carmen
    Vergara Gomez, Mercedes
    Gomez Dominguez, Elena
    Gallego Moya, Adolfo
    Perez-Medrano, Indhira
    Fabrega, Emilio
    Hernandez Guerra, Manuel
    Berenguer Haym, Marina
    Estevez, Pamela
    Arencibia Almeida, Ana
    Morillas, Rosa
    Horta, Diana
    Albillos, Agustin
    Casado, Marta
    De la Cruz, Gemma
    Fernandez Bonilla, Eva
    Molina, Esther
    Hijona, Lander
    Diago, Moises
    Fernandez Rodriguez, Conrado Manuel
    Gonzalez-Santiago, Jesus M.
    Sala, Margarita
    Gomez-Camarero, Judith
    Romero Gomez, Manuel
    Suarez, Francisco
    Vargas Blasco, Victor Manuel
    Ferre Aracil, Carlos
    Andrade, Raul J.
    Chahri, Nadia
    Pares, Albert
    JOURNAL OF HEPATOLOGY, 2020, 73 : S460 - S461
  • [3] New Guidelines on primary biliary Cholangitis: Obeticholic Acid (Ocaliva®) considered as the only approved Second-line Therapy
    不详
    VISCERAL MEDICINE, 2017, 33 (05) : 392 - 392
  • [4] Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue?
    Bittermann, Therese
    Schaubel, Douglas E.
    HEPATOLOGY, 2024,
  • [5] OBETICHOLIC ACID VERSUS FIBRATES AS SECOND-LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    de Abreu, Eliabe S.
    Cavalcante, Deivyd Vieira Silva
    Pitanga, Jorge Ferreira Jasmineiro
    Reginato, Pedro Henrique
    Borges, Pedro Neves
    de Araujo, Yoana Palatianos
    Zarpellon, Loren Angelica
    Santos, Ana Clara Felix de Farias
    Habib, Jaqueline Cardoso
    Cancado, Guilherme
    HEPATOLOGY, 2024, 80 : S1826 - S1827
  • [6] ADDITIVE BENEFICIAL EFFECTS OF FIBRATES COMBINED WITH OBETICHOLIC ACID IN THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO SECOND-LINE THERAPY
    Soret, Pierre-Antoine
    Lam, Laurent
    Carrat, Fabrice
    Smets, Lena
    Leroy, Vincent
    Berg, Thomas
    Carbone, Marco
    Invernizzi, Pietro
    Trivedi, Palak
    Weiler-Normann, Christina
    Alric, Laurent
    Rosa, Isabelle
    Cervoni, Jean-Paul
    Dumortier, Jerome
    Potier, Pascal
    Roux, Olivier
    Silvain, Christine
    Levy, Cynthia
    Pares, Albert
    Schramm, Christoph
    Nevens, Frederick
    Chazouilleres, Olivier
    Corpechot, Christophe
    HEPATOLOGY, 2019, 70 (06) : 1491A - 1492A
  • [7] In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis
    Lens, Sabela
    GASTROENTEROLOGY, 2024, 167 (03) : 623 - 624
  • [8] Obeticholic acid for primary biliary cholangitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (02): : 93 - 93
  • [9] Obeticholic Acid for Primary Biliary Cholangitis
    Floreani, Annarosa
    Gabbia, Daniela
    De Martin, Sara
    BIOMEDICINES, 2022, 10 (10)
  • [10] Obeticholic Acid in Primary Biliary Cholangitis
    van Golen, Rowan F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20):
12345